Literature DB >> 16944610

Efficacy of species specific anti-scorpion venom serum (AScVS) against severe, serious scorpion stings (Mesobuthus tamulus concanesis Pocock)--an experience from rural hospital in western Maharashtra.

V S Natu1, R K K Murthy, K P Deodhar.   

Abstract

BACKGROUND: Death caused by scorpion envenoming is a common event in the tropical and subtropical countries including many regions in India. Severe scorpion envenoming causes an autonomic storm producing multi-system organ-failure (MSOF) and death.
OBJECTIVES: To determine the efficacy of Anti-scorpion venom serum (AScVS) in patients stung by scorpions (Mesobuthus tamulus concanesis Pocock--earlier called Buthus tamulus); to compare it with other modalities of therapy and to detect complications, if any, arising out of AScVS treatment.
METHODS: Total 48 patients of severe, serious scorpion envenoming syndrome were studied during the period from 1992 to 2002. In 17 patients AScVS was the only mode of treatment. Others had received adjunctive therapy along with AScVS.
RESULTS: 47 patients out of 48 scorpion sting victims recovered completely. Recovery period in patients given AScVS (10 hours) was faster than those who received alpha blockers (16-42 hours). No anaphylactic reaction with AScVS was observed.
CONCLUSIONS: AScVS is effective and safe method of therapy in severe scorpion envenoming syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944610

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  6 in total

1.  Efficacy of Scorpion Antivenom in Grade III and IV Scorpion Envenomation.

Authors:  Rajniti Prasad; Abhishek Kumar; Om Prakash Mishra; Tej Bali Singh; Ankur Singh
Journal:  Indian J Pediatr       Date:  2018-04-27       Impact factor: 1.967

2.  Cardiac dysrhythmia produced by Mesobuthus tamulus venom involves NO-dependent G-Cyclase signaling pathway.

Authors:  Sadhana Kanoo; Maloy B Mandal; Anitha B Alex; Shripad B Deshpande
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-27       Impact factor: 3.000

3.  Efficacy and safety of scorpion antivenom plus prazosin compared with prazosin alone for venomous scorpion (Mesobuthus tamulus) sting: randomised open label clinical trial.

Authors:  Himmatrao Saluba Bawaskar; Pramodini Himmatrao Bawaskar
Journal:  BMJ       Date:  2011-01-05

4.  Anti-scorpion venom activity of Andrographis paniculata: A combined and comparative study with anti-scorpion serum in mice.

Authors:  Ranjana S Kale; Satish E Bahekar; Shailesh R Nagpure; Kartik J Salwe
Journal:  Anc Sci Life       Date:  2013-01

5.  The epidemiology of scorpion stings in tropical areas of Kermanshah province, Iran, during 2008 and 2009.

Authors:  Alireza Khatony; Alireza Abdi; Tahereh Fatahpour; Farhad Towhidi
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-11-05

Review 6.  Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.

Authors:  Rashmi Dixit; Jenny Herz; Richard Dalton; Robert Booy
Journal:  Vaccine       Date:  2016-01-20       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.